Anti-IBP4/ IGFBP4/ BP-4 functional antibody
Anti-IBP4/ IGFBP4/ BP-4 functional antibody for cell culture, ELISA & in-vivo assay
Go to IGFBP4/IGFBP4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0986-Ab-1/ GM-Tg-hg-SE0986-Ab-2 | Anti-Human IGFBP4 monoclonal antibody | Human |
GM-Tg-rg-SE0986-Ab-1/ GM-Tg-rg-SE0986-Ab-2 | Anti-Rat IGFBP4 monoclonal antibody | Rat |
GM-Tg-mg-SE0986-Ab-1/ GM-Tg-mg-SE0986-Ab-2 | Anti-Mouse IGFBP4 monoclonal antibody | Mouse |
GM-Tg-cynog-SE0986-Ab-1/ GM-Tg-cynog-SE0986-Ab-2 | Anti-Cynomolgus/ Rhesus macaque IGFBP4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0986-Ab-1/ GM-Tg-felg-SE0986-Ab-2 | Anti-Feline IGFBP4 monoclonal antibody | Feline |
GM-Tg-cang-SE0986-Ab-1/ GM-Tg-cang-SE0986-Ab-2 | Anti-Canine IGFBP4 monoclonal antibody | Canine |
GM-Tg-bovg-SE0986-Ab-1/ GM-Tg-bovg-SE0986-Ab-2 | Anti-Bovine IGFBP4 monoclonal antibody | Bovine |
GM-Tg-equg-SE0986-Ab-1/ GM-Tg-equg-SE0986-Ab-2 | Anti-Equine IGFBP4 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0986-Ab-1/ GM-Tg-hg-SE0986-Ab-2; GM-Tg-rg-SE0986-Ab-1/ GM-Tg-rg-SE0986-Ab-2; GM-Tg-mg-SE0986-Ab-1/ GM-Tg-mg-SE0986-Ab-2; GM-Tg-cynog-SE0986-Ab-1/ GM-Tg-cynog-SE0986-Ab-2; GM-Tg-felg-SE0986-Ab-1/ GM-Tg-felg-SE0986-Ab-2; GM-Tg-cang-SE0986-Ab-1/ GM-Tg-cang-SE0986-Ab-2; GM-Tg-bovg-SE0986-Ab-1/ GM-Tg-bovg-SE0986-Ab-2; GM-Tg-equg-SE0986-Ab-1/ GM-Tg-equg-SE0986-Ab-2 |
Products Name | Anti-IGFBP4 monoclonal antibody |
Format | mab |
Target Name | IGFBP4 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-IGFBP4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0986-Ag-1 | Recombinant multi-species IBP4/ IGFBP4/ BP-4 protein |
Cytokine | GM-Tg-g-SE0986-Ag-1 | insulin-like growth factor binding protein 4 (IGFBP4) protein |
ORF Viral Vector | vGMLP003022 | human IGFBP4 Lentivirus particle |
ORF Viral Vector | pGMLP003022 | human IGFBP4 Lentivirus plasmid |
ORF Viral Vector | pGMLPm002827 | mouse Igfbp4 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002827 | mouse Igfbp4 Lentivirus particle |
Target information
Target ID | GM-SE0986 |
Target Name | IGFBP4 |
Gene ID | 3487,16010,360622,700963,608158,101082792,282262,100034062 |
Gene Symbol and Synonyms | BP-4,Deb2,HT29-IGFBP,IBP-4,IBP4,IGF-BP4,IGFBP-4,IGFBP4 |
Uniprot Accession | P22692,P21744,Q05716 |
Uniprot Entry Name | IBP4_HUMAN,IBP4_RAT,IBP4_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Cytokine Target |
Disease | Pancreas Cancer, Dent disease |
Gene Ensembl | ENSG00000141753 |
Target Classification | N/A |
The target: IGFBP4, gene name: IGFBP4, also named as BP-4, HT29-IGFBP, IBP4, IGFBP-4. This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.